The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development?
Open accessAbstract
The world of human immunodeficiency virus (HIV) vaccines has suffered a baffling setback. The first trial of a vaccine designed to elicit strong cellular immunity has shown no protection against infection. More alarmingly, the vaccine appeared to increase the rate of HIV infection in individuals with prior immunity against the adenovirus vector used in the vaccine. A new study in this issue suggests that a different vaccine approach—using a DNA prime/poxvirus boost strategy—induces polyfunctional immune responses to an HIV immunogen. The disappointing results of the recent vaccine trial suggest that a more thorough assessment of vaccine-induced immune responses is urgently needed, and that more emphasis should be placed on primate models before efficacy trials are undertaken.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Restoring function in exhausted CD8 T cells during chronic viral infection
Barber, D. L., Wherry, E. J., Masopust, D., Zhu, B., Allison, J. P., Sharpe, A. H., Freeman, G. J., & Ahmed, R. (2006) · Nature · doi:10.1038/nature04444 · Cited by 3,986
PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression
Day, C. L., Kaufmann, D. E., Kiepiela, P., Brown, J. A., Moodley, E. S., Reddy, S., Mackey, E. W., Miller, J. D., Leslie, A. J., DePierres, C., et al. (2006) · Nature · doi:10.1038/nature05115 · Cited by 2,680
Control of Viremia in Simian Immunodeficiency Virus Infection by CD8 + Lymphocytes
Schmitz, J. E., Kuroda, M. J., Santra, S., Sasseville, V. G., Simon, M. A., Lifton, M. A., Racz, P., Tenner-Racz, K., Dalesandro, M., Scallon, B. J., et al. (1999) · Science · doi:10.1126/science.283.5403.857 · Cited by 2,187
HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells
Betts, M. R. (2006) · Blood · doi:10.1182/blood-2005-12-4818 · Cited by 1,826
Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction
Trautmann, L., Janbazian, L., Chomont, N., Said, E. A., Gimmig, S., Bessette, B., Boulassel, M.-R., Delwart, E., Sepulveda, H., Balderas, R. S., et al. (2006) · Nature Medicine · doi:10.1038/nm1482 · Cited by 1,565
Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major
Darrah, P. A., Patel, D. T., De Luca, P. M., Lindsay, R. W. B., Davey, D. F., Flynn, B. J., Hoff, S. T., Andersen, P., Reed, S. G., Morris, S. L., et al. (2007) · Nature Medicine · doi:10.1038/nm1592 · Cited by 1,378
Shiver, J. W., Fu, T.-M., Chen, L., Casimiro, D. R., Davies, M.-E., Evans, R. K., Zhang, Z.-Q., Simon, A. J., Trigona, W. L., Dubey, S. A., et al. (2002) · Nature · doi:10.1038/415331a · Cited by 1,176
Migueles, S. A., Laborico, A. C., Shupert, W. L., Sabbaghian, M. S., Rabin, R., Hallahan, C. W., Baarle, D. V., Kostense, S., Miedema, F., McLaughlin, M., et al. (2002) · Nature Immunology · doi:10.1038/ni845 · Cited by 1,005
Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4
Gilchrist, M., Thorsson, V., Li, B., Rust, A. G., Korb, M., Kennedy, K., Hai, T., Bolouri, H., & Aderem, A. (2006) · Nature · doi:10.1038/nature04768 · Cited by 803
HIV vaccine design and the neutralizing antibody problem
Burton, D. R., Desrosiers, R. C., Doms, R. W., Koff, W. C., Kwong, P. D., Moore, J. P., Nabel, G. J., Sodroski, J., Wilson, I. A., & Wyatt, R. T. (2004) · Nature Immunology · doi:10.1038/ni0304-233 · Cited by 765
Translating Innate Immunity into Immunological Memory: Implications for Vaccine Development
Pulendran, B., & Ahmed, R. (2006) · Cell · doi:10.1016/j.cell.2006.02.019 · Cited by 625
Querec, T., Bennouna, S., Alkan, S., Laouar, Y., Gorden, K., Flavell, R., Akira, S., Ahmed, R., & Pulendran, B. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051720 · Cited by 552
Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity
Roberts, D. M., Nanda, A., Havenga, M. J. E., Abbink, P., Lynch, D. M., Ewald, B. A., Liu, J., Thorner, A. R., Swanson, P. E., Gorgone, D. A., et al. (2006) · Nature · doi:10.1038/nature04721 · Cited by 491
Pantaleo, G., & Koup, R. A. (2004) · Nature Medicine · doi:10.1038/nm0804-806 · Cited by 444
Systems Biology: Its Practice and Challenges
Aderem, A. (2005) · Cell · doi:10.1016/j.cell.2005.04.020 · Cited by 444
Preserved CD4+ Central Memory T Cells and Survival in Vaccinated SIV-Challenged Monkeys
Letvin, N. L., Mascola, J. R., Sun, Y., Gorgone, D. A., Buzby, A. P., Xu, L., Yang, Z.-Y., Chakrabarti, B., Rao, S. S., Schmitz, J. E., et al. (2006) · Science · doi:10.1126/science.1124226 · Cited by 372
Sumida, S. M., Truitt, D. M., Lemckert, A. A. C., Vogels, R., Custers, J. H. H. V., Addo, M. M., Lockman, S., Peter, T., Peyerl, F. W., Kishko, M. G., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.11.7179 · Cited by 369
Harari, A., Bart, P.-A., Stöhr, W., Tapia, G., Garcia, M., Medjitna-Rais, E., Burnet, S., Cellerai, C., Erlwein, O., Barber, T., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071331 · Cited by 300
Harari, A., Vallelian, F., Meylan, P. R., & Pantaleo, G. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.2.1037 · Cited by 284
Sun, Z., Denton, P. W., Estes, J. D., Othieno, F. A., Wei, B. L., Wege, A. K., Melkus, M. W., Padgett-Thomas, A., Zupancic, M., Haase, A. T., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062411 · Cited by 282
Replicating and non-replicating viral vectors for vaccine development
Robert-Guroff, M. (2007) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2007.10.010 · Cited by 275
Casimiro, D. R., Wang, F., Schleif, W. A., Liang, X., Zhang, Z.-Q., Tobery, T. W., Davies, M.-E., McDermott, A. B., O'Connor, D. H., Fridman, A., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.24.15547-15555.2005 · Cited by 271
McMichael, A. J. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090605 · Cited by 246
Immunity and immunological memory following smallpox vaccination
Amanna, I. J., Slifka, M. K., & Crotty, S. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00392.x · Cited by 231
Ling, B., Veazey, R. S., Luckay, A., Penedo, C., XU, K., Lifson, J. D., & Marx, P. A. (2002) · AIDS · doi:10.1097/00002030-200207260-00005 · Cited by 228
T cell vaccines for microbial infections
Robinson, H. L., & Amara, R. R. (2005) · Nature Medicine · doi:10.1038/nm1212 · Cited by 216
Overcoming Immunity to a Viral Vaccine by DNA Priming before Vector Boosting
Yang, Z.-Y., Wyatt, L. S., Kong, W.-P., Moodie, Z., Moss, B., & Nabel, G. J. (2003) · Journal of Virology · doi:10.1128/jvi.77.1.799-803.2003 · Cited by 204
Can successful vaccines teach us how to induce efficient protective immune responses?
Lambert, P.-H., Liu, M., & Siegrist, C.-A. (2005) · Nature Medicine · doi:10.1038/nm1216 · Cited by 187
Progress and obstacles in the development of an AIDS vaccine
Letvin, N. L. (2006) · Nature Reviews Immunology · doi:10.1038/nri1959 · Cited by 176
Adenovirus Vector-Based Vaccines for Human Immunodeficiency Virus Type 1
Barouch, D. H., & Nabel, G. J. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.149 · Cited by 168
Adenovirus types 5 and 35 seroprevalence in AIDS risk groups supports type 35 as a vaccine vector
Kostense, S., Koudstaal, W., Sprangers, M., Weverling, G. J., Penders, G., Helmus, N., Vogels, R., Bakker, M. E., Berkhout, B., Havenga, M. J. E., et al. (2004) · AIDS · doi:10.1097/00002030-200405210-00019 · Cited by 156
HIV-1 infection and pathogenesis in a novel humanized mouse model
Zhang, L., Kovalev, G. I., & Su, L. (2006) · Blood · doi:10.1182/blood-2006-07-033159 · Cited by 143
Pontesilli, O., Klein, M. R., Kerkhof‐Garde, S. R., Pakker, N. G., de Wolf, F., Schuitemaker, H., & Miedema, F. F. (1998) · The Journal of Infectious Diseases · doi:10.1086/515659 · Cited by 99
Did Merck's Failed HIV Vaccine Cause Harm?
Cohen, J. (2007) · Science · doi:10.1126/science.318.5853.1048 · Cited by 98
Hel, Z., Tsai, W.-P., Thornton, A., Nacsa, J., Giuliani, L., Tryniszewska, E. A., Poudyal, M., Venzon, D. J., Wang, X., Altman, J. D., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.12.7180 · Cited by 92
Non-Human Primate Models for AIDS Vaccine Research
Hu, S.-L. (2005) · Current Drug Targets - Infectious Disorders · doi:10.2174/1568005054201508 · Cited by 92
Liang, X., Casimiro, D. R., Schleif, W. A., Wang, F., Davies, M.-E., Zhang, Z., Fu, T., Finnefrock, A. C., Handt, L., Citron, M. P., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.19.12321-12331.2005 · Cited by 77
Santra, S., Barouch, D. H., Korioth-Schmitz, B., Lord, C. I., Krivulka, G. R., Yu, F. H., Beddall, M. H., Gorgone, D. A., Lifton, M. A., Miura, A., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401954101 · Cited by 59
Inhibition of HIV‐1 entry by antibodies: potential viral and cellular targets
Phogat, S. K., Wyatt, R. T., & Hedestam, G. B. K. (2007) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2007.01820.x · Cited by 51
Scientific and policy challenges to development of an AIDS vaccine
Berkley, S., & Koff, W. C. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61054-x · Cited by 50
Robinson, H. L. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100408 · Cited by 49
Ledford, H. K. (2007) · Nature · doi:10.1038/450325a · Cited by 42
Cited by
Viral vector platforms within the gene therapy landscape
Bulcha, J. T., Wang, Y., Ma, H., Tai, P. W. L., & Gao, G. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00487-6 · Cited by 1,404
Variation in the Human Immune System Is Largely Driven by Non-Heritable Influences
Brodin, P., Jojic, V., Gao, T., Bhattacharya, S., Angel, C. J. L., Furman, D., Shen-Orr, S., Dekker, C. L., Swan, G. E., Butte, A. J., et al. (2015) · Cell · doi:10.1016/j.cell.2014.12.020 · Cited by 1,065
HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysis
McElrath, M. J., De Rosa, S. C., Moodie, Z., Dubey, S., Kierstead, L., Janes, H., Defawe, O. D., Carter, D. K., Hural, J., Akondy, R., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61592-5 · Cited by 713
Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses
Gaucher, D., Therrien, R., Kettaf, N., Angermann, B. R., Boucher, G., Filali-Mouhim, A., Moser, J. M., Mehta, R. S., Drake, D. R., Castro, E., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20082292 · Cited by 594
Self-citationDevelopments in Viral Vector-Based Vaccines
Ura, T., Okuda, K., & Shimada, M. (2014) · Vaccines · doi:10.3390/vaccines2030624 · Cited by 436
Metadata
- Authors
- Sekaly, R.-P.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2008-01-14
- Volume
- 205
- Issue
- 1
- Pages
- 7-12
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2163787552
- Cited by
- 400
- References
- 42
- FWCI
- 23.02
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.